JP2011510654A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011510654A5 JP2011510654A5 JP2010545017A JP2010545017A JP2011510654A5 JP 2011510654 A5 JP2011510654 A5 JP 2011510654A5 JP 2010545017 A JP2010545017 A JP 2010545017A JP 2010545017 A JP2010545017 A JP 2010545017A JP 2011510654 A5 JP2011510654 A5 JP 2011510654A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- hybridoma
- antigen
- fragment
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6258408P | 2008-01-28 | 2008-01-28 | |
| PCT/US2009/000562 WO2009105150A2 (en) | 2008-01-28 | 2009-01-28 | Method of making hybrid cells that express useful antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015009809A Division JP5923186B2 (ja) | 2008-01-28 | 2015-01-21 | 有用な抗体を発現する雑種細胞の作成方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011510654A JP2011510654A (ja) | 2011-04-07 |
| JP2011510654A5 true JP2011510654A5 (https=) | 2012-03-15 |
Family
ID=40986086
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010545017A Pending JP2011510654A (ja) | 2008-01-28 | 2009-01-28 | 有用な抗体を発現する雑種細胞の作成方法 |
| JP2015009809A Active JP5923186B2 (ja) | 2008-01-28 | 2015-01-21 | 有用な抗体を発現する雑種細胞の作成方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015009809A Active JP5923186B2 (ja) | 2008-01-28 | 2015-01-21 | 有用な抗体を発現する雑種細胞の作成方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8999707B2 (https=) |
| EP (1) | EP2242836B1 (https=) |
| JP (2) | JP2011510654A (https=) |
| WO (1) | WO2009105150A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7563874B2 (en) | 1998-08-31 | 2009-07-21 | The Regents Of The University Of California | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| WO2009008916A2 (en) | 2007-03-22 | 2009-01-15 | The Regents Of The University Of Californina | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| WO2009131605A2 (en) * | 2008-01-28 | 2009-10-29 | Thomas Jefferson University | Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
| EP2307453A1 (en) * | 2008-06-16 | 2011-04-13 | University Of Zurich | Method of providing immunoglobulin secreting b lymphocytes and human antibodies |
| US9000131B2 (en) | 2008-07-31 | 2015-04-07 | The Regents Of The University Of California | Antibodies that neutralize botulinum neurotoxins |
| US8821879B2 (en) | 2009-09-04 | 2014-09-02 | Xoma Technology Ltd. | Anti-botulism antibody coformulations |
| US20110059079A1 (en) * | 2009-09-04 | 2011-03-10 | Xoma Technology Ltd. | Antibody Coformulations |
| SI2400298T1 (sl) * | 2010-05-28 | 2013-11-29 | F. Hoffmann-La Roche Ag | Postopek kultivacije posamezne B-celice in izdelava specifičnih protiteles |
| US9243057B2 (en) | 2010-08-31 | 2016-01-26 | The Regents Of The University Of California | Antibodies for botulinum neurotoxins |
| CN103429615B (zh) * | 2010-12-02 | 2018-03-16 | 埃姆医疗有限公司 | 用于生产高亲和力抗体的方式和方法 |
| EP2724157B1 (en) | 2011-06-27 | 2017-03-08 | Valneva | Method for screening cells |
| ES2617488T3 (es) * | 2011-11-23 | 2017-06-19 | F. Hoffmann-La Roche Ag | Células de mamífero que expresan CD40L y su uso |
| US10017739B2 (en) | 2012-09-06 | 2018-07-10 | Duke University | Methods of expanding and assessing B cells and using expanded B cells to treat disease |
| WO2014138733A2 (en) * | 2013-03-08 | 2014-09-12 | Dessain Scott K | Compositions and methods for making human antibodies |
| US20160014600A1 (en) * | 2014-07-10 | 2016-01-14 | Bank Of America Corporation | Identification of Potential Improper Transaction |
| US20160253708A1 (en) * | 2015-02-26 | 2016-09-01 | Dropbox, Inc. | Method and system for efficiently serving upsell content based on complex user archetypes |
| US10729771B2 (en) * | 2016-02-10 | 2020-08-04 | Rutgers, The State University Of New Jersey | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections |
| WO2018112407A1 (en) | 2016-12-15 | 2018-06-21 | Duke University | Antibodies and methods for depleting regulatory b10 cells and use in combination with immune checkpoint inhibitors |
| JP2022501062A (ja) | 2018-10-02 | 2022-01-06 | イムノーム、インコーポレイテッド | Ｅｐｎ１を標的とする抗体 |
| WO2022150809A1 (en) | 2021-01-05 | 2022-07-14 | Immunome, Inc. | Antibody cocktail against sars-cov-2 spike protein |
| CN114350606A (zh) * | 2022-01-05 | 2022-04-15 | 上海药明生物医药有限公司 | 一种富集大鼠浆细胞及建立浆细胞杂交瘤的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3150991B2 (ja) * | 1991-04-10 | 2001-03-26 | 協和醗酵工業株式会社 | ハイブリドーマの製造法 |
| US6541225B1 (en) * | 2000-01-26 | 2003-04-01 | Raven Biotechnologies, Inc. | Methods and compositions for generating human monoclonal antibodies |
| AU2002357932A1 (en) * | 2001-12-18 | 2003-06-30 | Whitehead Institute For Biomedical Research | Fusion partner cells and uses thereof |
| WO2005052139A2 (en) * | 2003-11-19 | 2005-06-09 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Method of inducing memory b cell development and terminal differentiation |
| EP1928999B1 (en) * | 2005-08-23 | 2011-04-13 | IQ Corporation | Methods of producing stable b-lymphocytes |
| WO2009131605A2 (en) * | 2008-01-28 | 2009-10-29 | Thomas Jefferson University | Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
-
2009
- 2009-01-28 EP EP09713631.1A patent/EP2242836B1/en active Active
- 2009-01-28 JP JP2010545017A patent/JP2011510654A/ja active Pending
- 2009-01-28 WO PCT/US2009/000562 patent/WO2009105150A2/en not_active Ceased
- 2009-01-28 US US12/864,889 patent/US8999707B2/en active Active
-
2015
- 2015-01-21 JP JP2015009809A patent/JP5923186B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011510654A5 (https=) | ||
| JP2022177090A5 (https=) | ||
| JP2022523442A5 (https=) | ||
| RU2020120539A (ru) | Композиции для ингибирования masp-2-зависимой активации комплемента | |
| JP2011526785A5 (https=) | ||
| HRP20191697T1 (hr) | Vezujuće molekule za bcma i cd3 | |
| JP2020534830A5 (https=) | ||
| RU2012142230A (ru) | Антитела против csf-1r человека и их применение | |
| KR20210100654A (ko) | Cd3 항체 및 그의 약제학적 용도 | |
| IL273196B1 (en) | Claudin 6 antibodies and methods of cancer treatment | |
| RU2012147638A (ru) | Антитела против растворимого st-2 человека и способы анализа | |
| JP2013520984A5 (https=) | ||
| JP2020504101A5 (https=) | ||
| HRP20131215T1 (hr) | Antagonistiäśka humana monoklonska protutijela specifiäśna za humane slabe epitope | |
| JP2015508056A5 (https=) | ||
| RU2012142231A (ru) | Антитела против csf-1r человека и их применение | |
| RU2008129111A (ru) | Антитела к ox40l и способы их применения | |
| RU2014103784A (ru) | Антитело, блокирующее agr2, и его применение | |
| NZ603226A (en) | Anti-c5a antibodies and methods for using the antibodies | |
| FI3322727T3 (fi) | Humanisoituja tai kimeerisiä CD3-vasta-aineita | |
| RU2009126766A (ru) | Антитела человека к дельта-подобному лиганду-4 человека | |
| RU2013142600A (ru) | Белки, связывающие специфический мембранный антиген простаты, и соответствующие композиции и способы | |
| NZ597067A (en) | Monoclonal antibodies expressed by ATCC PTA-4621 for the treatment of cancer | |
| JP2011527899A5 (https=) | ||
| JP2012523848A5 (https=) |